Mackey Edward F 4
4 · BOSTON SCIENTIFIC CORP · Filed Jan 3, 2022
Insider Transaction Report
Form 4
Mackey Edward F
EVP, Operations
Transactions
- Exercise/Conversion
Common Stock
2022-01-01+9,824→ 33,546 total - Tax Payment
Common Stock
2022-01-01$42.48/sh−3,068$130,329→ 30,478 total - Exercise/Conversion
Performance Share Units
2022-01-01−9,824→ 0 totalFrom: 2021-12-31Exp: 2021-12-31→ Common Stock (9,824 underlying)
Footnotes (2)
- [F1]On February 21, 2019, the reporting person was awarded a target number of performance share units under the Company's 2019 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2019 adjusted free cash flow measured against its 2019 financial plan over the one-year performance period ending December 31, 2019 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2021.
- [F2]Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.